SciGenom Announces Industry Oriented Phd Program in Collaboration with CHARUSAT University

To develop future-ready scientists from India in breakthrough technologies, SciGenom Labs, a genomics company with facilities in India (Cochin, Chennai, Hyderabad) and the USA (San Francisco) announced a unique Industry based Ph.D. program to support research in the disciplines of Genomics, Proteomics, Microbiome and Bio-Nanotech in collaboration with CHARUSAT University. This industry-academia collaboration will provide students with an opportunity to participate in research activities with multiple international universities and scientists from independent research institutions to find solutions to real-world problems that plague humanity, while working in SciGenom.

The students should have qualified in one of the National Eligibility Tests for Junior Research Fellowship such as (NET-JRF) CSIR-UGC, DBT, GATE and INSPIRE. The selected students will be registered with CHARUSAT university while working with one of the leading companies under the SciGenom group of companies. The selected researchers will be provided with an additional stipend during their Ph.D. program in addition to the government fellowship. Admissions will start in September 2022 and will continue throughout the year.

Commenting on the program, Mr.Sam Santhosh, Founder & Chairman, SciGenom, said, “SciGenom has always contributed towards advanced research in the areas of genomics and precision medicine through multiple initiatives that are being driven globally. With the collaboration between SciGenom and CHARUSAT – An A+ Grade University, we hope to develop breakthroughs in Precision Medicine, Environmental remediation and Agricultural productivity. Simultaneously, we are working towards the preservation of the rich bio-cultural diversity and heritage of India through our ‘Hortus Malabaricus- Medicinal Plant Garden’ started by SciGenom Research Foundation (SGRF) in 2016.  Therefore, this partnership will further strengthen the goal of SciGenom of developing an integrated ecosystem of science-focused entrepreneurs through incubation, proof of concept validation, international collaborations, talent development and funding.”

Dr. R.V. Upadhyay, Provost, CHARUSAT, said, “CHARUSAT is a top-ranked University of the nation having A+ grade from NAAC. Research and Development are adopted as the flywheel by CHARUSAT to propel its teaching-learning as well as societal development activities. This Ph.D. program in collaboration with SciGenom is aimed at addressing the talent crunch in the industry and contributing to building the research and development capacity of India. With the support of SciGenom, we will be able to get our students to collaborate with national and international universities resulting in globally recognised solutions in the area of cancer management, environmental sustainability and food security.”

This Ph.D. program with CHARUSAT will be India’s unique program where the students will get an opportunity to directly work on live projects with an industrial body in their specialised field. CHARUSAT currently holds the distinction of being the 22nd top university in India.  

For more details. Please visit www.scigenom.com

 

 

Comments

Post a Comment

Popular posts from this blog

First DPL match was won by US Consulate Staff Team

Image
  ICWO - Indian Community Welfare Organisation  organized the First DPL- Diplomat Cricket Tournament for Embassy, Consulate & High Commission Staff on 10 th   August 2024 at Soka Ikeda College of Arts and Science for Women, Sethu Bhaskara Nagar, Madhanangkuppam, Kolathur, Chennai. T he event aims to create high level Awareness to STOP Child Abuse, Child Trafficking, Child Marriage & Child Labour in Tamilnadu and mobilize funds for intervention to address the same. A.J.Hariharan, Secretary – ICWO thanked both the US Consulate and Malaysian Consulate for their support and participation in the diplomate cricket tournament as to create an awareness about the Child Marriage, Child Trafficking & Child Labour and Child Abuse in Tamilnadu. The tournament has created huge interest among the players and the consul officials. We, ICWO have plan to organize similar event on 3 rd  May 2025. This time for men and women doubles badminton tournament. We emphasis there is...
Read more

TATA AIG Strengthens Tamil Nadu Health Insurance Portfolio with New Riders amid Strong Growth

Image
Chennai, 12 November 2024: TATA AIG General Insurance, a leading general insurance provider in India, is strengthening its health insurance offerings in Tamil Nadu with five specialised riders: Mental Wellbeing, Empower Her, OPD Care, CanCare, and Flexi Shield. These riders are specifically designed to address the unique and diverse healthcare needs of the state’s residents, providing enhanced protection in areas such as mental health, women’s health, cancer treatment, and routine medical costs. TATA AIG has established a robust presence across 31 districts in Tamil Nadu, with key branches in Chennai, Coimbatore, Madurai, Tiruchirapalli, Tirunelveli, and Salem. The company’s expansive network includes over 1000 hospitals, ensuring seamless access to cashless treatment for its customers across both urban and rural regions. With a well-established network of agents and digital platforms, the company is bringing quality health insurance solutions to every corner of the state. This pe...
Read more

Apollo Cancer Centers now introduces Made in India, CAR T Cell Program

Image
First Private Hospital in India to Successfully Complete CAR T Cell Therapy.  In a ground-breaking development, Apollo Cancer Centres (ACCs) has emerged as the first private hospital group in India to have a successfully complete CAR-T cell program and to further augment it, the group will now provide access to Made in India CAR-T cell therapy, beginning with NexCAR19 (Actalycabtagene autoleucel), for the treatment of B-cell lymphomas and B-acute lymphoblastic leukaemia in patients aged 15 years and above.   Marking a historic moment in the country's medical landscape , Dr. T Raja, Director of Medical Oncology at ACC, Chennai, spearheaded the development of this revolutionary clinical program, and has successfully treated six patients till date.   CAR-T cell therapies, often known as living drugs involve the extraction of a patients T-cells (a type of white blood cells whose function is to fight cancer cells) through a process known as Apheresis. These T-cells are t...
Read more